ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Diabetes: Molecular Mechanisms
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1652178
This article is part of the Research TopicEndocrinology of Aging: Advances in Molecular Biology and Metabolic DiseasesView all articles
Shared Senescence-associated Gene Networks in PCOS and T2DM: Biomarker Identification and Functional Validation
Provisionally accepted- 1College of Traditional Chinese Medicine,Changchun University Of Chinese Medicine, Changchun, China
- 2Changchun Orthopaedics Hospital, Changchun, China
- 3Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China
- 4Changchun University of Chinese Medicine, Changchun, China
- 5Gynecology Department, Affliated Hospital of Changchun University of Chinese Medicine, Changchun, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
(1) Background: Polycystic ovary syndrome (PCOS) and type 2 diabetes mellitus (T2DM) are two prevalent and interrelated disorders that pose an increasingly significant global health burden. Cellular senescence may represent a pivotal process driving the progression of both conditions. Senescent cells, through the senescence-associated secretory phenotype (SASP), can induce chronic inflammation, which is highly likely to exacerbate the pathological progression of PCOS and T2DM. However, the molecular pathways linking cellular senescence to PCOS and T2DM have not yet been systematically elucidated. (2) Methods The transcriptome datasets of PCOS (GSE54248) and T2DM (GSE23561) were obtained from the GEO database, and differentially expressed genes (DEGs) were screened using the limma package. Age-related DEGs (ARDEGs) were obtained by intersecting DEGs with age-related genes, and the protein-protein interaction (PPI) network was constructed based on the STRING database. Hub genes with diagnostic value were determined via the Wilcoxon rank sum test and receiver operating characteristic (ROC) curve. CIBERSORT was used to analyze the infiltration characteristics of immune cells, and the functions of the hub gene were analyzed by gene set enrichment analysis (GSEA). Single-cell sequencing was used to locate gene expression patterns, and qRT‒PCR was used to verify the expression of candidate genes in clinical samples. (3) Results: 80 DEGs between PCOS and T2DM samples were obtained, and 15 ARDEGs were identified. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that they were related to inflammatory response and immune response, and were involved in specific functions and pathways. Four hub genes were identified: TUBA4A, RTN1, G6PD, and HP. qRT‒PCR experimental results showed that HP, G6PD, TUBA4A, and RTN1 were highly expressed in the peripheral blood of PCOS and T2DM patients, compared to healthy people. (4) This study revealed the potential connections between PCOS, T2DM, and aging-related molecular networks and signaling pathways and discovered multiple potential therapeutic targets. It provides new intervention directions for clinicians, especially based on aging mechanisms.
Keywords: Bioinformatics analysis, Hub genes, Molecular interaction networks, senescence-associated secretory phenotype, Polycystic Ovary Syndrome, Type 2diabetes
Received: 23 Jun 2025; Accepted: 09 Sep 2025.
Copyright: © 2025 Kong, Lou, Liu, Dai, Li, Yang, Zhang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xin Chen, Gynecology Department, Affliated Hospital of Changchun University of Chinese Medicine, Changchun, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.